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Edited by Sandro SonninoAbstract Analyzing peroxisomal phosphoinositide (PId#) syn-
thesis in highly puriﬁed rat liver peroxisomes we found synthesis
of phosphatidylinositol 4-phosphate (PtdIns4P), PtdIns(4,5)P2
and PtdIns(3,5)P2. PtdIns3P was hardly detected in vitro, how-
ever, was observed in vivo after [32P]-phosphate labeling of pri-
mary rat hepatocytes. In comparison with other subcellular
organelles peroxisomes revealed a unique PId pattern suggesting
peroxisomal speciﬁcity of the observed synthesis. Use of phos-
phatase inhibitors enhanced the amount of PtdIns4P. The results
obtained provide evidence that isolated rat liver peroxisomes syn-
thesize PIds and suggest the association of PId 4-kinase and PId
5-kinase and PId 4-phosphatase activities with the peroxisomal
membrane.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: Peroxisomes; Phosphoinositides;
Phosphatidylinositol kinases; Phosphatidylinositol
phosphatases; Phosphoinositide monophosphate;
Phosphoinositide bisphosphate1. Introduction
Recently published data provide evidence that in Saccharo-
myces cerevisiae Pex3p, an early peroxin, inserts into the mem-
brane of the endoplasmic reticulum (ER) and transport to
peroxisomes requires its interaction with Pex19p [1]. In mouse
dendritic cells an ER-derived structure containing Pex13p and
the 70 kDa peroxisomal membrane protein (PMP) was pro-
posed to be involved in the biogenesis of mammalian peroxi-
somes [2]. While these observations suggest the ER to play a
dominant role in the formation of new peroxisomes, studies
on the expression of Pex11ap and Pex11bp in mammalian cellsAbbreviations: ARF, ADP ribosylation factor; PtdIns, phosphatidyl-
inositol; PIP, phosphoinositide monophosphate; PIP2, phosphoinosi-
tide bisphosphate; PIP3, phosphoinositide trisphosphate; PId,
phosphoinositide; PtdIns4P, phosphatidylinositol(4)-phosphate;
PtdIns(3,5)P2, phosphatidylinositol(3,5)-bisphosphate; PtdIns(4,5)P2,
phosphatidylinositol(4,5)-bisphosphate; PtdOH, phosphatidic acid;
PMP, peroxisomal membrane protein; TLC, thin layer chromato-
graphy
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doi:10.1016/j.febslet.2006.09.058indicated that during peroxisome proliferation new peroxi-
somes might develop from pre-existing ones [3]. The involve-
ment of the ER raises many questions as for example to the
way of transport, the implication of coat proteins, the target
membranes for vesicle fusion or the existence of an ER-per-
oxisome shuttle. Recently, a model on peroxisome prolifera-
tion has been proposed based on the observation of multiply
constricted peroxisomes implying formation of peroxisomal
membrane clusters accumulating distinct PMPs, constriction
of tubular peroxisomes and ﬁnal ﬁssion of peroxisomal vesicles
[4,5]. Thus, formation of ER-derived and peroxisome-derived
peroxisomes might represent multistep processes implying a
number of components, such as the small GTPases ARF and
RhoA and the dynamin-like protein 1 (DLP1) to peroxisomes
[6–8]. Whereas DLP1 might be implicated in a late step of per-
oxisome proliferation, RhoA was proposed to mediate actin
assembly on peroxisomes [9]. ARF and coatomer recruitment
were ﬁrst identiﬁed on Golgi membranes and the molecular
mechanisms leading to the formation of COP I-coated vesicles
were elucidated [10,11]. The process serves the vesicular trans-
port of cargo molecules both in anterograde and retrograde
direction [12]. In addition, ARF was shown to be involved in
the recruitment of the clathrin coat [13], the control of phos-
pholipase D (PLD) [14] and the membrane association of
phosphoinositide (PId)-speciﬁc kinases to the Golgi complex
[15].
The GTP-dependent recruitment of ARF/coatomer to per-
oxisomes [16] suggested ARF-GAPs and ARF-GEFs being
implicated in ARF activation. Its insensitivity to brefeldin A
(BFA) suggested a member of the low molecular weight
ARF-GEFs to be involved [17]. As these ARF-GEFs within
their common domain structure contain a pleckstrin homology
(PH) domain mediating PIds binding, we investigated peroxi-
somal PId synthesis. We found that isolated peroxisomes in
the presence of [c-32P]ATP synthesize a unique pattern of
peroxisomal PIds consisting of PtdIns4P, PtdIns(3,5)P2 and
PtdIns(4,5)P2. Whereas PtdIns4P synthesis was predominantly
observed in gradient fractions of rat liver homogenate that
were rich in endosomal/lysosomal activities, PIP2 synthesis
was maximal in peroxisomes.2. Materials and methods
2.1. [32P]-Phosphate labeling of primary rat hepatocytes
Highly puriﬁed peroxisomes, ER and mitochondria were isolated as
previously described [18]. Primary rat hepatocytes were prepared [19]
and plated in 10 cm dishes at 3.7 · 106 cells/dish. Cells (20 dishes) wereblished by Elsevier B.V. All rights reserved.
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Amersham Biosciences, Freiburg, Germany) per dish in a phosphate
free medium. The post-nuclear supernatant (PNS) was loaded on top
of a 14–45% (w/v) Nycodenz gradient and centrifuged in a TV865 rotor
at 30000 rpm for 1 h [18]. Labeled phospholipids were extracted,
deacylated and analyzed by high pressure liquid chromatography
(HPLC, see below). Protein, phospholipid phosphate and the activities
of acid phosphatase and 5 0-nucleotidase were determined as described
[18,20,21].
2.2. Preparation of [32P]-labeled PId standards
Radioactive PtdIns3P, PtdIns(3,4)P2, PtdIns(3,5)P2 and
PtdIns(3,4,5)P3 standards were prepared by phosphorylating either
phosphatidylinositol (PtdIns), PtdIns4P, PtdIns5P or PtdIns(4,5)P2
integrated into phosphatidylserine-based liposomes with human re-
combinant PId 3-kinase (Alexis Biochemicals, Gru¨nberg, Germany)
in the presence of [c-32P]ATP. [32P]PtdIns4P was synthesized by label-
ing PtdIns-containing liposomes with PId 4-kinase b immunoprecipi-
tated from rat liver cytosol as described [22].
2.3. Incubations and radioactive labeling of cell organelles
Peroxisomes (10 nmol phospholipid phosphate corresponding to
50 lg of protein) were resuspended in 20 ll labeling buﬀer (25 mM
HEPES, pH 7.2, 125 mM potassium acetate, 5 mM magnesium ace-
tate, 1 mM DTT) and incubated in a total volume of 100 ll containing
4 lCi [c-32P]ATP (400 lCi/lmol) for varying times at 37 C. Phospha-
tase inhibitors were used in a 1:100 dilution of Phosphatase Inhibitor
Cocktail 2 (Sigma–Aldrich Chemie, Munich, Germany). Reactions
were stopped by the addition of 100 ll 1 M HCl and phospholipids ex-
tracted using 400 ll chloroform:methanol (1:1). The organic layer was
washed once using 400 ll chloroform:1 M HCl (1:1) and after drying
the organic phase under a stream of N2 the extracted lipids were dis-
solved in chloroform:methanol (1:1). For labeling of rough ER micro-
somes and mitochondria we followed exactly the same procedure as
used for peroxisomes. In some experiments prelabeled peroxisomes
were reisolated and further incubated in labeling buﬀer in the presence
or absence of phosphatase inhibitors.
2.4. Chromatographic separations
Thin layer chromatography (TLC) was performed as described in
[23]. The labeled substances were detected by phosphoimaging (Bio-
Rad, Munich, Germany) and quantiﬁed. For HPLC labeled PIds
(250 lCi [c-32P]ATP, 1.25 mCi/lmol) were obtained from peroxisomes
(200 nmol phospholipid phosphate), extracted and the dried lipids
deacylated with approximately 50% recovery [24] . HPLC analysis
(Merck-Hitachi LaChrom Elite system, VWR, Darmstadt, Germany,
equipped with a radioactivity detector, Raytest, Straubenhardt, Ger-
many) was done as described [25] using a Partisphere SAX 5 lmWhat-Fig. 1. In vitro synthesis and characterization of peroxisomal PIds. (A) Repre
highly puriﬁed rat liver peroxisomes (10 nmol phospholipid phosphate). Aft
TLC (1% oxalate-pretreated silica gel plates; 1-propanol:2 M acetic acid
Identiﬁcation of [c-32P]-labeled peroxisomal PIds (solid line) by HPLC after
(broken line) used for the identiﬁcation were prepared as described in
PtdIns(4,5)P2 and PtdIns(3,5)P2. The substance eluting at a retention time oman column 4.6 · 250 mm (Fisher Scientiﬁc, Schwerte, Germany) and
a 0–250 mM ammonium phosphate buﬀer gradient of pH 3.8 over
60 min and at a ﬂow rate of 1 ml/min.
2.5. Antibodies
For immunoblotting antibodies were used directed against PMP70p,
Pex11ap (peroxisomal membrane proteins) [26], calnexin (an ER-local-
ized chaperone, Stressgen, Biomol, Germany), the F1-ATPase (mito-
chondrial inner membrane protein, Santa Cruz Biotechnology,
Heidelberg, Germany), EEA1 (endosomal marker protein, BD Biosci-
ences, Heidelberg, Germany). The anti-PtdIns 4-kinase b antibody was
from Biomol (Hamburg, Germany) and the anti-rabbit peroxidase-
labeled secondary antibodies were from (Dianova, Hamburg, Germany).3. Results
3.1. Synthesis and identiﬁcation of peroxisomal PIds
To investigate peroxisomal PId synthesis, we used highly
puriﬁed peroxisomes from rat liver. Based on marker enzyme
activities the peroxisome fraction isolated from cloﬁbrate-trea-
ted rat livers was >95% pure. The high purity of this prepara-
tion was achieved at the expense of organelle yield. The
isolated peroxisome fraction represented about 20% of the
total hepatic population. The major contamination in this frac-
tion was derived from ER microsomes [18]. Mitochondrial,
endosomal, Golgi and plasma membrane markers were low
or even not detected [16]. This peroxisomal preparation was
used in the experiments described in Figs. 1, 3, 5 and 6. In
Fig. 1A we show the phospholipids extracted from these
peroxisomes after [c-32P]ATP-labeling. Phosphoimaging of
the labeled lipids following their TLC separation revealed ﬁve
radioactive spots. Four of them, phosphatidic acid (PtdOH),
PtdIns, phosphatidylinositol monophosphate (PIP), and phos-
phatidylinositol bisphosphate (PIP2) showed identical chro-
matographic behavior as the corresponding phospholipid
standards. The substance migrating between PIP and PIP2,
designated PX, has not been identiﬁed yet.
To further characterize the synthesized PId species, the lipids
extracted after [c-32P]ATP-labeling were deacylated and the
deacylation products subjected to HPLC. The results obtained
are shown in Fig. 1B. By comparing the elution proﬁles of per-sentative pattern of peroxisomal PIds following [c-32P]ATP-labeling of
er labeling for 30 min the phospholipids were extracted, separated by
65:35) and the radioactive spots visualized by phosphoimaging. (B)
extraction and deacylation of the labeled phospholipids. Standard PIds
Section 2. The PIds identiﬁed in peroxisomes included PtdIns(4)P,
f 47 min was no known PId and not identiﬁed so far.
B. Jeynov et al. / FEBS Letters 580 (2006) 5917–5924 5919oxisomal PIds with those of internal PId standards four [32P]-
phosphate labeled PIds were identiﬁed. In the group of syn-
thesized PIPs PtdIns4P was the major constituent. PtdIns3P
was only detected in very small amounts. The group of PIP2
consisted of two species similar in concentration that coeluted
with retention times identical to that of PtdIns(3,5)P2 and
PtdIns(4,5)P2. The substance eluting between PtdIns4P and
PtdIns(3,5)P2 possibly refers to PX seen in the TLC. There is
no known PId species eluting with a retention time corre-
sponding to PX [24].
3.2. Peroxisomal speciﬁcity of PId synthesis
Speciﬁcity of peroxisomal PId synthesis was proven by den-
sity gradient separation of the subcellular organelles of a rat
liver PNS and comparison of the PId-synthesizing activitiesFig. 2. PId synthesis in subcellular fractions of a rat liver post-nuclear supern
organelles of each fraction were reisolated and subjected to [c-32P]ATP-labe
Note that in lanes 2–7 10% and in lanes 8–11 1% of the gradient fractions w
fractions used for analysis, however, are taken into account in the densitom
organelles was determined by SDS–PAGE and Western blotting using antibo
mitochondria; early endosomal autoantigen 1 (EEA1), early endosomes; PM
lanes 8–11 4 ll of the gradient fractions were used for the SDS gel. (C) Lysoso
activities were determined enzymatically and given as percentage of the total a
nmol phospholipid phosphate) were determined as the ratio of synthesized PI
phosphate content in each fraction. (E,F) The in vitro synthesized PIds in fra
amounts of fractions 8/9 were analyzed accordingly, and the elution proﬁleof the various fractions. To keep PId synthesis within linearity
labeling of the density gradient fractions was done for 5 min
(see Fig. 6). After extraction the labeled phospholipids were
separated by TLC and quantiﬁed by phosphoimaging. In all
gradient fractions speciﬁc organelle markers were analyzed
by SDS–PAGE and Western blotting. Lysosomal acid phos-
phatase and plasma membrane 5 0-nucleotidase activities were
determined enzymatically. The results of these analyses are
shown in Fig. 2. The TLC pattern of synthesized PIds is largely
dominated by the high amount of PIP predominantly appear-
ing in gradient fractions 8–10 containing microsomes, endo-
somes and lysosomes (Fig. 2A–C). Approximately 5% of
total PIP appeared in fractions 3/4 containing peroxisomes
of about 90% purity. The gradient distribution of PIP2 con-
spicuously followed the distribution of the peroxisomal markeratant separated by Nycodenz density gradient centrifugation. (A) The
ling for 5 min. Synthesized PIds were extracted and analyzed by TLC.
ere used for the labeling. These diﬀerences in the amount of gradient
etric representation of synthesized PIds. (B) The distribution of cell
dies speciﬁc for various organelle markers (calnexin, ER; F1-ATPase,
P70p and Pex11ap, peroxisomes). Note that in lanes 1–7 15 ll and in
mal (acid phosphatase) and plasma membrane (5 0 nucleotidase) marker
ctivity in the gradient. (D) PIP and PIP2-speciﬁc activities (density/min/
P or PIP2 per minute (as quantiﬁed in A) to the measured phospholipid
ction 9 (E) and fraction 3 (F) were further analyzed by HPLC. Higher
of the PIP2 species is shown as inset in E.
Fig. 3. Comparison of PId-synthesis in isolated highly puriﬁed
peroxisomes, ER and mitochondria. (A,B) Distinct amounts of
peroxisomes (Pox), ER microsomes (ER) and mitochondria (Mito)
based on their phospholipid phosphate content were subjected to
SDS–PAGE and immunoblotting. Antibodies directed against
Pex11ap (peroxisomal marker), calnexin (ER marker) and F1-ATPase
(mitochondrial marker) were used to estimate ER and mitochondrial
contamination of the isolated peroxisomes. The signals obtained were
quantiﬁed by densitometry. The numbers on top of the bars represent
percentage intensities of the calnexin (A) and the F1-ATPase (B)
signals setting the values obtained from 4 nmol ER and 4 nmol
mitochondria as 100%. (C) Synthesis of peroxisomal but not ER and
mitochondrial PIds is inhibited by wortmannin and LY294002 by
about 30%. Equal amounts of peroxisomes, ER and mitochondria,
based on phospholipid phosphate content (10 nmol), were in vitro
labeled for 30 min by [c-32P]ATP in the absence () and presence of
wortmannin (W, 500 nM) or LY294002 (LY, 2 lM). After labeling,
phospholipids were extracted, separated by TLC and quantiﬁed by
phosphoimaging.
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other in fractions 6/7 (Fig. 2B). This isopycnic heterogeneity
of hepatic peroxisomes is known and has been described previ-
ously [27]. The two peroxisomal populations might be func-
tionally distinct, as enhanced protein import competence has
been attributed to the lower density population of fractions
6/7 [28]. This population colocalizes with mitochondria (F1-
ATPase), however, as puriﬁed mitochondria do not synthesize
PIP2 (see below Fig. 3C), PIP2 synthesized in fractions 6/7
might also be of peroxisomal origin. Major contaminants of
peroxisomes in fractions 3/4 were ER microsomes (calnexin),
lysosomes (acid phosphatase) and plasma membrane (5 0-nucle-
otidase). Golgi (GM130, a cis-Golgi tethering protein [16]) and
endosomal (EEA1) contaminants were not seen (Fig. 2B and
C). The absence of these contaminants from the peroxisomal
fraction and lack of considerable synthesis of PIP2 in fractions
8–11 clearly suggests that peroxisomes synthesize PIP2. HPLC
analysis of PIP synthesized in fraction 9 was identiﬁed as
PtdIns4P. In order to characterize PIP2 higher amounts of
organelles of fractions 8/9 had to be applied (Fig. 2E inset).
The analysis revealed PtdIns(4,5)P2 but not PtdIns(3,5)P2. In
the peroxisomal fractions 3/4 PIP was also identiﬁed as
PtdIns4P. PtdIns3P was present, however, in only very small
amounts. PIP2 consisted of a mixture of PtdIns(3,5)P2 and
PtdIns(4,5)P2 in a concentration ratio of 4.5:1 (Fig. 2F). The
peroxisomal contribution (fraction 3/4) to total PIP synthesis
was estimated to be 2.5%. Since lysosomal contamination of
the peroxisomal fraction was calculated to be about 3%, no
ﬁrm conclusions could be drawn from these experiments for
a peroxisomal PIP synthesis.
Synthesis of PIP2 in peroxisomes might suggest that the
enzymes involved are present in highest speciﬁc activity in
the peroxisomal fraction. Therefore, in addition to PIP and
PIP2 synthesis we analyzed protein and phospholipid phos-
phate content in each fraction and determined the speciﬁc
activity of PId synthesis throughout the gradient. Highest spe-
ciﬁc activity (density/min/nmol of phospholipid phosphate) of
PIP2 synthesis was noted in peroxisomes of fraction 3 exhibit-
ing a speciﬁc activity about 10 times higher than that in frac-
tion 9. This situation was diﬀerent for the synthesis of PIP
for which highest speciﬁc activity was measured in fraction
10. Compared to these fractions the speciﬁc activity in peroxi-
somes of fraction 3 was about 3-fold decreased (Fig. 2D).
The density gradient separation of the PNS favorably of-
fered the possibility to reveal the distribution of most of the
cellular PId-kinase activities raising, however, the problem of
less pure individual organelle fractions. We therefore also
investigated PId synthesis in highly puriﬁed peroxisomes and
compared these activities with those determined in rough
microsomes and mitochondria, two organelles expected to
represent major contaminants of the isolated peroxisomes.
To this end, diﬀerent organelle concentrations based on both
their protein (not shown) and phospholipid content were
applied to SDS-gels and speciﬁc marker proteins were blotted.
ER contamination on a protein base was about 3% and on a
phospholipid base and calnexin as the ER marker protein it
was about 8% (Fig. 3A). Using F1-ATPase as a mitochondrial
marker, mitochondrial contamination was estimated to be less
than 1% (Fig. 3B). The pattern of PIds synthesized in vitro by
equivalent amounts of peroxisomes, ER and mitochondria are
shown in Fig. 3C. The peroxisomal pattern is clearly domi-
nated by the high concentration of PIP2 that is nearly absentfrom the ER and the mitochondrial preparations. In ER and
mitochondria PIP is the dominating species and PX that is
present in peroxisomes does not occur in ER and mito-
chondria. By HPLC analysis ER and mitochondrial PIP was
identiﬁed as PtdIns4P (not shown). We also tested the suscep-
tibility of the kinases involved in these reactions to the inhibi-
tors wortmannin and LY294002. Particularly, wortmannin in
low nanomolar concentrations speciﬁcally inhibits PtdIns 3-ki-
Fig. 4. Identiﬁcation of peroxisomal PIds synthesized in primary rat
hepatocytes metabolically labeled with [32P]-phosphate. (A) In vivo
labeled hepatocyte peroxisomes were isolated by Nycodenz density
gradient centrifugation and their lipids extracted and analyzed by
HPLC. (B) To prove the identity of the PIP/PIP2 species in (A) the run
was repeated by mixing the peroxisome extract with synthetic [32P]-
labeled PId-standards. The proﬁle of the applied standards is shown as
inset in (B). Note that PtdIns(3)P, PtdIns(4)P and PtdIns(4,5)P2 were
identiﬁed in these in vivo peroxisomes. Diﬀerent to the in vitro labeling
no PtdIns(3,5)P2 was found.
Fig. 5. Peroxisomal PId phosphatases. (A) Highly puriﬁed peroxisomes (10 n
in either the absence (PINs) or presence (+PINs) of a phosphatase in
phosphoimaging. (B) The signals obtained were quantiﬁed by densitometry se
deviations of 3 independent experiments are given. (C) Prelabeled peroxiso
(PINs) or presence (+PINs) of phosphatase inhibitors; the extracted lipids w
of PIP, PX and PIP2 is shown in (D).
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PId kinases [29]. Whereas ER and mitochondrial activities
were not inﬂuenced, peroxisomal PIP synthesis was reduced
by about 30% and PIP2 synthesis by about 20% aﬀecting syn-
thesis of PtdIns(4,5)P2 but not PtdIns(3,5)P2 (not shown).
These data suggest that the enzymes present on peroxisomes
are distinct from those in ER and mitochondria.
Synthesis of PtdIns(3,5)P2 most likely requires the transient
formation of PtdIns3P that is subsequently converted to
PtdIns(3,5)P2 by the activity of a PtdIns 5-kinase. However,
incubation of isolated peroxisomes with [c-32P]ATP provided
no ﬁrm indication for PtdIns3P synthesis suggesting active
PtdIns 3-kinase not to be associated with peroxisomal mem-
branes. We therefore investigated the presence of PtdIns3P
in peroxisomes isolated from [32P]-phosphate-labeled primary
hepatocytes. In fraction 3 of this gradient containing the
majority of peroxisomes (Fig. 4) we found low but signiﬁcant
amounts of PtdIns3P together with PtdIns4P and
PtdIns(4,5)P2.
3.3. Peroxisomal PId phosphatases
The actual cellular level of PIds is adjusted by the activities
of PtdIns- and PId-kinases and PId-phosphatases. We studied
the putative existence of peroxisomal PId-phosphatases by
unbalancing the phosphorylation/dephosphorylation activities
using a cocktail of phosphatase inhibitors containing vana-
date, molybdate, imidazole, ﬂuoride and tartrate. When pres-
ent during labeling these inhibitors remarkably changed the
pattern of peroxisomal PIds in that the concentration of PIP
on the average increased 2–3-fold and formation of PX was
considerably reduced. The concentration of peroxisomal PIP2
was only slightly aﬀected (Fig. 5A and B). We also tested
the eﬀect of the inhibitors on puriﬁed ER microsomes andmol phospholipid phosphate) were labeled for 30 min with [c-32P]ATP
hibitor cocktail. The extracted lipids were analyzed by TLC and
tting the values of the control assay (i.e. PINs) as 100%. The standard
mes were incubated in buﬀer for the indicated times in the absence
ere analyzed by TLC and phosphoimaging. The densitometric analysis
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increase in the concentration of PIP, respectively, and no inﬂu-
ence on PIP2 (not shown). Degradation of PIP2 by PId
phosphatases was also observed when [c-32P]ATP-labeled
peroxisomes were reisolated and further incubated in buﬀer.
Under these conditions PIP2 decreased by about 60–70%,
whereas PIP and PX slightly increased in concentration
(Fig. 5C and D). In the presence of phosphatase inhibitors
PIP2 hydrolysis was diminished and the concentration of PIP
increased (Fig. 5C and D).
Time course analysis of the synthesis of PIP, PX and PIP2 in
peroxisomes in the absence and presence of phosphatase inhib-
itors demonstrated that these inhibitors did not signiﬁcantly
aﬀect the general kinetics of PIP, PX and PIP2 formation
(Fig. 6). PX was synthesized more slowly and the steady state
level of PIP was about doubled. In the absence of inhibitors
PIP2 was synthesized with an initial rate of incorporation of
radioactivity about three times higher than PIP. Both PIPFig. 6. Time course of the labeling of peroxisomal PIds. Highly
puriﬁed peroxisomes (10 nmol phospholipid phosphate) were
labeled with [c-32P]ATP in the absence (PINs) or presence (+PINs)
of phosphatase inhibitors, the extracted phospholipids separated by
TLC and the radioactive spots visualized by phosphoimaging and
quantiﬁed. For each set of experiments the density of highest intensity
is set to 100%. The graphs represent the average of six independent
experiments. Time course of the labeling of PIP (A) and PIP2 (B), time
course of the labeling of PX (C).and PIP2 after about 10 min reached steady state concentra-
tions that remained constant for up to one hour.4. Discussion
4.1. Synthesis of peroxisomal PIds
In the present paper we describe the synthesis of PtdIns4P,
PtdIns(4,5)P2 and PtdIns(3,5)P2 in isolated rat liver peroxi-
somes. Comparing the synthesizing activity of peroxisomes
with that of the organelles present in the PNS of a rat liver
homogenate, we concluded that synthesis of PtdIns(4,5)P2
and PtdIns(3,5)P2 observed in the peroxisome-containing frac-
tions is largely peroxisomal and not due to contamination of
the peroxisomal fraction by other cell organelles. Since
PtdIns(4,5)P2 production requires synthesis of PtdIns4P, we
further conclude that some portion of PtdIns4P synthesized
in peroxisomal fractions is actually made in peroxisomes.
From the data available up to now and from what is known
in the literature we hypothesized on how these peroxisomal
PIds were synthesized. Their time dependent formation
showed that the rate of 32P-phosphate incorporation into
PIP2 was about two times that of PIP suggesting at least por-
tions of labeled PIP to be utilized for PIP2 synthesis. This
might particularly include the synthesis of PtdIns(4,5)P2 utiliz-
ing 32P-phosphate-labeled PtdIns4P as a substrate. The use of
phosphatase inhibitors resulted in an about 2-fold increase in
the synthesis of PtdIns4P most likely by inhibiting a PtdIns4P
phosphatase activity (Figs. 5 and 6).
The pathway of PtdIns(3,5)P2 synthesis is less clear. As we
found low levels of PtdIns3P in isolated peroxisomes (Fig. 4),
one way to synthesize PtdIns(3,5)P2 might be the conversion
of PtdIns3P to PtdIns(3,5)P2 by a PtdIns3P 5-kinase. The fact
that the synthesis of PtdIns(3,5)P2 is not inhibited by wortman-
nin and LY294002 argues for the absence of PtdIns 3-kinase
activity from the isolated peroxisomes (Fig. 3). Alternatively,
PtdIns(3,5)P2 could have been synthesized by hydrolysis
of PtdIns(3,4,5)P3, although an appropriate PtdIns(3,4,5)P3 4-
phosphatase has not been described yet. However, as there
were no indications for the in vitro synthesis of PtdIns(3,4,5)P3
in peroxisomes and incubation of PtdIns(3,4,5)P3 with
detergent-solubilized peroxisomes did not show PtdIns(3,4,5)P3
dephosphorylation (not shown), this pathway is rather unlikely.
4.2. PId-kinases and PId-phosphatases acting on peroxisomes
Both in vitro and in vivo labeling experiments supported the
view that PId 4-kinase and PId 5-kinase activities remained
membrane-associated during peroxisome isolation. Consistent
with this idea is the fact that PId 4-kinases are predominantly
membrane-bound enzymes found so far on both the plasma
membrane and various intracellular membranes [29,30]. PId
5-kinases have been described in mammals to occur in two dis-
tinct types, type I and type II [31]. The human type I kinases a
and b also termed PI5KIA and PI5KIB can phosphorylate
PtdIns to PtdIns5P and PtdIns3P to PtdIns(3,5)P2 in vitro
[32]. So far we have no indication for the presence of PtdIns5P
in peroxisomes arguing for the phosphorylation of PtdIns3P to
synthesize PtdIns(3,5)P2.
The fact that isolated peroxisomes in vitro synthesize
PtdIns(3,5)P2 but not PtdIns3P suggested that PtdIns 3-kinase
is active in vivo but not in vitro. In vitro synthesis of higher
amounts of PtdIns(3,5)P2 only were detected in peroxisomes
Fig. 7. Domain structure of the human ortholog of YlPex23. DKFZP434B0335 protein was subjected to standard search in conserved domain
database [37]. The relevant domains are indicated. DysFN, Dysferlin domain, N-terminal region; DysFC, Dysferlin domain, C-terminal region.
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(Fig. 2). The absence or presence of organelle-speciﬁc regula-
tors, e.g. the Rho family members (Cdc 42, Rac and Rho), the
rab family members (rab11 and rab5) or ARF, as they were
shown to be implicated in regulating the phosphorylation/
dephosphorylation cycle on distinct organelle membranes,
might be responsible for the diﬀerences in the observed synthetic
activity in vitro and in vivo [33–35]. Furthermore, the activities
of the mammalian PI5KIA and B were shown to be subject to
regulation by PtdOH stimulating the enzymes about 10-fold
[36]. TLC analysis of peroxisomes labeled in vitro revealed syn-
thesis of PtdOH (Fig. 1) and changes in its concentration were
frequently observed during the course of these experiments.
Comparative experiments between ER, mitochondria and
peroxisomes in the absence or presence of wortmannin and
LY294002 demonstrated diﬀerences in the sensitivity of the
various PId-kinases to these inhibitors. Whereas on per-
oxisomes these inhibitors reduced the synthesis of PIP, the
ER and mitochondrial enzymes were only slightly aﬀected
(Fig. 3C) suggesting that the PId kinases present on peroxi-
somes are distinct from those localized to other subcellular
compartments.
Beside PId-kinases, PId-phosphatases might also locate to
peroxisomes. Several experiments provided indication for
peroxisomal PId-phosphatase activity. Hydrolysis of PIds in
[c-32P]ATP-prelabeled peroxisomes was observed when these
peroxisomes were further incubated with buﬀer. Under the
same conditions radiolabeled PIds contained in protein-free lip-
osomes were not hydrolyzed (not shown). Furthermore, a sig-
niﬁcant increase in the synthesis of PIP was seen upon
labeling of peroxisomes in the presence of phosphatase inhibi-
tors (Fig. 5A and B). As we did not observe protein phosphor-
ylation in peroxisomes, the data obtained may be simply
interpreted as the inhibition of a peroxisomal PtdIns4P phos-
phatase activity.
4.3. Possible role of peroxisomal PIds
Various eﬀectors of PtdIns(4,5)P2 and PtdIns(3,5)P2 are
known that interact through a set of PId-binding modules,
such as the PH, FYVE and PHOX homology domains
as well as the ENTH and ANTH domains [33]. Interest-ingly, the human ortholog of Yarrowia lipolytica Pex23p
(DKFZP434B0335) contains both a PH domain and b-propel-
ler domains [37] (Fig. 7). Whereas PH domains preferably
interact with PtdIns(4,5)P2, some b-propeller proteins speciﬁ-
cally bind to PtdIns(3,5)P2 [38]. In addition, PtdIns(4,5)P2
and PtdIns(3,5)P2 were recently hypothesized to be putatively
involved in peroxisomal fusion processes [39] in regulating the
peroxisomal AAA-ATPases Pex1p, a NSF homolog, and
Pex6p [40] and cf. [41–43] and directing actin rearrangements
through interaction with several actin-binding proteins [44]
and various small GTPases, such as Rho, Rac and ARF
[45,46]. As RhoA, ARF1 and ARF6 were recently described
to recruit to peroxisomes [9,16,26] and are actively involved
in regulating membrane traﬃc [47], peroxisomal PIds might
also be implicated in shuttle processes between peroxisomes
and the ER or in peroxisomal proliferation [4,16].
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